Literature DB >> 1175676

The effect of yohimbine on the turnover of brain catecholamines and serotonin.

R Papeschi, P Theiss.   

Abstract

Yohimbine moderately increased the depletion of brain dopamine (DA) after alpha-methyl-p-tyrosine (AMT) only when the two drugs were given at the same time; the baseline concentration of brain homovanillic acid (HVA) and its accumulation after probenecid were strongly increased by yohimbine. Yohimbine markedly decreased the concentration of brain noradrenaline (NA), both when given alone and before or at the same time as AMT; when it was given at an increasing interval after AMT, the effect became progressively smaller. The baseline concentration of brain 3-methyoxy-4-hydroxyphenylethyleneglycol sulphate and its accumulation after probenecid were increased by yohimbine; this effect was not as marked as that on HVA and was proportional to the quantity of NA depleted in the Amt method. The accumulation of brain k-hydroxyindoleacetic acid after probenecid was decreased by yohimbine pretreatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1175676     DOI: 10.1016/0014-2999(75)90131-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

Authors:  P C Waldmeier; R Ortmann; S Bischoff
Journal:  Experientia       Date:  1982-10-15

2.  The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.

Authors:  A Söderpalm; F Ehrenström; B Söderpalm
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Prompt arousal from fentanyl-droperidol-pentobarbital anesthesia in dogs: a preliminary study.

Authors:  R C Hatch; A D Jernigan; R C Wilson; I B Lipham; N H Booth; J D Clark; J Brown
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

4.  Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.

Authors:  P Valet; M Taouis; M A Tran; P Montastruc; M Lafontan; M Berlan
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

5.  Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

Authors:  D J Pettibone; B V Clineschmidt; V J Lotti; J J Baldwin; J R Huff; W C Randall; J Vacca; S D Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

6.  The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.

Authors:  J C van Oene; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

7.  Yohimbine both increases and decreases nociceptive thresholds in rats: evaluation of the dose-response relationship.

Authors:  G H Paalzow; L K Paalzow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.